MedTrace Logo

Esmya Versus Surgery Before IVF/ICSI

NCT04028986 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-05-16

No results posted yet for this study

Summary

Studying the possible outcome differences between surgery or medical treatment with ulipristalacetate (UPA) solely before 'in-vitro fertilisation/intracytoplasmic sperm injection' (IVF/ICSI) treatment in infertile couples.

Conditions

  • Fibroid; Uterus Tumor, Complicating Pregnancy
  • Infertility, Female
  • Surgical Procedure, Unspecified

Interventions

DRUG

Ulipristal Acetate 5 MG Oral Tablet

use of ulipristalacetate OR surgery before fertility treatment

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2025-12-31
Completion
2026-06-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04028986 on ClinicalTrials.gov